| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 890-902 |
| Número de páginas | 13 |
| Publicación | American Journal of Health-System Pharmacy |
| Volumen | 81 |
| N.º | 18 |
| DOI |
|
| Estado | Published - sept 15 2024 |
Financiación
This project was supported in part by the National Institutes of Health (NIH) under award K23DK128562 (principal investigator, Dr. Flannery) and K08DK124658 (principal investigator, Dr. Miano). The funding source had no role in study design; data collection, analysis, or interpretation; writing the report; or the decision to submit the report for publication. Dr. Flannery currently serves as an associate editor for AJHP. The other authors have declared no potential conflicts of interest.
| Financiadores | Número del financiador |
|---|---|
| National Institutes of Health (NIH) | K08DK124658, K23DK128562 |
ODS de las Naciones Unidas
Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible
-
Good health and well being
ASJC Scopus subject areas
- Pharmacy
- Pharmacology
- Health Policy
Huella
Profundice en los temas de investigación de 'The times are changing: A primer on novel clinical trial designs and endpoints in critical care research'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver